Sublime Therapeutics Private Limited - Company Profile

It is a trading private limited company based in Ahmedabad, Gujarat, India, established in 2008.
2008 Ahmedabad, Gujarat, India Struck Off
Last Updated:
Access Report
About Sublime Therapeutics Private Limited

Sublime Therapeutics Private Limited, a struck off private limited company, was established on 25 August 2008 in Ahmedabad, Gujarat, India. Engaging in wholesale within the trading sector, it holds CIN: U24230GJ2008PTC054859. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Siddharthan Kunjakan Kaknat (Director), Naresh Sharma (Director), Pramod Kundan Lal Bhardwaj (Director). Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at 61/3,Jalaram Estate, Near Railway Crossing, Sarkhej Highway,, Ahmedabad, Gujarat, 382210.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2008PTC054859

  • Registration Number

    054859

  • Incorporation Date

    25 August 2008

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 17 Year, 5 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Sublime Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sublime Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sublime Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Siddharthan Kunjakan Kaknat Director 25 Aug 2008 Current
Naresh Sharma Director 25 Aug 2008 Current
Pramod Kundan Lal Bhardwaj Director 25 Aug 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sublime Therapeutics.

Enhance accessibility to Sublime Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sublime Therapeutics revenue growth over time
Sublime Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sublime Therapeutics?

Unlock access to Sublime Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sublime Therapeutics?

Unlock and access historical data on people associated with Sublime Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sublime Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sublime Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sublime Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Sublime Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Sublime Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Ahmedabad. was documented.

  • Director Appointment

    The activity Siddharthan Kunjakan Kaknat was appointed as a Director was appointed as a Director on 25 Aug 2008 & has been associated with this company since 17 years 5 months . was completed.

  • Director Appointment

    Progress on Naresh Sharma was appointed as a Director was appointed as a Director on 25 Aug 2008 & has been associated with this company since 17 years 5 months . was documented.

  • Director Appointment

    The activity Pramod Kundan Lal Bhardwaj was appointed as a Director was appointed as a Director on 25 Aug 2008 & has been associated with this company since 17 years 5 months . was completed.

  • Company Incorporation

    Progress on Sublime Therapeutics Private Limited was registered on 25 Aug 2008 with Roc Ahmedabad & aged 17 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sublime Therapeutics Private Limited?

The CIN of Sublime Therapeutics Private Limited is U24230GJ2008PTC054859.

Where is Sublime Therapeutics Private Limited headquartered?

Sublime Therapeutics Private Limited is headquartered at 61/3,Jalaram Estate, Near Railway Crossing, Sarkhej Highway,, Ahmedabad, Gujarat, 382210.

When was Sublime Therapeutics Private Limited incorporated?

Sublime Therapeutics Private Limited was incorporated on 25 August 2008.

Who are the current directors of Sublime Therapeutics Private Limited?

The current directors of Sublime Therapeutics Private Limited are

What is the primary industry of Sublime Therapeutics Private Limited?

The primary industry of Sublime Therapeutics Private Limited is Trading.

Is Sublime Therapeutics Private Limited a listed company?

Sublime Therapeutics Private Limited is unlisted.

What is the capital structure of Sublime Therapeutics Private Limited?

The authorized capital of Sublime Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available